Reliance reported record third-quarter 2026 net sales of $5.21 billion, up 42.8% from a year earlier, and diluted EPS of $7.84 versus $3.59. Non-GAAP EPS of $8.02 exceeded management's guidance of $6.40 to $6.60, and the company guided fourth-quarter non-GAAP EPS to $7.40 to $7.60 while raising its share repurchase authorization to $2.5 billion.
Third-quarter net sales were $5.21 billion, up 42.8% year over year, with tons sold up 15.6%.
Diluted EPS was $7.84 versus $3.59 a year earlier; non-GAAP diluted EPS was $8.02 versus guidance of $6.40 to $6.60.
Fourth-quarter 2026 non-GAAP diluted EPS is expected in the range of $7.40 to $7.60.
The Board approved raising the share repurchase authorization to $2.5 billion on October 20, 2026, and declared a $1.25 quarterly dividend payable December 4, 2026.
Reliance reported second quarter 2026 net sales of $4.63 billion, up 15% from the first quarter and 26.5% from a year earlier, with diluted EPS of $6.29 versus $4.42 a year earlier. Non-GAAP EPS of $6.27 exceeded the high end of management's $5.15 to $5.35 guidance range, though LIFO expense of $1.64 per share was well above the $0.54 management had expected. The company guided to third quarter non-GAAP EPS of $6.40 to $6.60.
Net sales $4.63 billion, up 15% sequentially and 26.5% year-over-year; pretax income $429.8 million, up 41% year-over-year
Non-GAAP EPS $6.27 versus management guidance of $5.15 to $5.35; LIFO expense $1.64 per share versus $0.54 expected
Third quarter 2026 non-GAAP EPS guidance of $6.40 to $6.60, including about $0.60 from the U.S. border wall project
Quarterly dividend of $1.25 per share declared July 17, 2026, payable August 28, 2026
Reliance reported first-quarter 2026 net sales of $4.0 billion, up 15.1% year over year, and diluted EPS of $5.10, up from $3.74 a year earlier. Non-GAAP diluted EPS of $5.16 was above management's $4.50 to $4.70 guidance, and the company guided second-quarter non-GAAP EPS to $5.15 to $5.35.
Diluted EPS $5.10 versus $3.74 in Q1 2025; non-GAAP diluted EPS $5.16, up 37% year over year
Net sales $4.0 billion, up 15.1% year over year; tons sold 1,672.7 thousand, up 2.7% year over year
Q2 2026 non-GAAP EPS guidance of $5.15 to $5.35, including about $0.15 to $0.20 from the DHS border wall contract
Repurchased $234.2 million of common stock in the quarter; quarterly dividend of $1.25 per share payable June 5, 2026
Reliance reported fourth-quarter 2025 net sales of $3.5 billion, up 11.9% from a year earlier, with tons sold up 5.8%. Non-GAAP diluted EPS of $2.40 came in below management's $2.65 to $2.85 guidance range; the company said that normalizing for LIFO and tax impacts would have placed it within guidance at $2.65. Full-year 2025 diluted EPS fell 10.2% to $13.98, and the company guided first-quarter 2026 non-GAAP EPS to $4.50 to $4.70.
Q4 2025 net sales $3.5 billion, up 11.9% year over year; diluted EPS $2.22 versus $1.93 a year earlier
Q4 non-GAAP diluted EPS $2.40 versus management guidance of $2.65 to $2.85, including a $0.25 per share unfavorable LIFO and tax true-up
Full-year 2025 net sales $14.3 billion, up 3.3%; diluted EPS $13.98, down 10.2%
Q1 2026 non-GAAP EPS guidance $4.50 to $4.70; quarterly dividend of $1.25 per share payable March 20, 2026
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
